Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-8,970
Closed -$758K 142
2023
Q3
$758K Sell
8,970
-4,817
-35% -$435K 0.38% 57
2023
Q2
$1.36M Sell
13,787
-1,524
-10% -$143K 0.61% 41
2023
Q1
$1.47M Hold
15,311
0.67% 43
2022
Q4
$1.39M Sell
15,311
-1,715
-10% -$146K 0.63% 44
2022
Q3
$1.35M Sell
17,026
-512
-3% -$43.4K 0.83% 34
2022
Q2
$1.46M Sell
17,538
-989
-5% -$81.5K 0.82% 31
2022
Q1
$1.52M Sell
18,527
-92
-0.5% -$7.21K 0.77% 35
2021
Q4
$1.39M Hold
18,619
0.65% 42
2021
Q3
$1.41M Hold
18,619
0.73% 36
2021
Q2
$1.44M Sell
18,619
-790
-4% -$61K 0.73% 38
2021
Q1
$1.36M Sell
19,409
-12,426
-39% -$939K 0.77% 35
2020
Q4
$2.26M Buy
31,835
+8,122
+34% +$510K 1.35% 19
2020
Q3
$1.36M Buy
23,713
+6,111
+35% +$365K 0.99% 25
2020
Q2
$1.07M Sell
17,602
-2,192
-11% -$135K 0.91% 28
2020
Q1
$1.09M Sell
19,794
-28
-0.1% -$1.88K 1.02% 29
2019
Q4
$1.43M Buy
19,822
+28
+0.1% +$1.91K 1.09% 27
2019
Q3
$1.31M Hold
19,794
0.97% 25
2019
Q2
$1.23M Hold
19,794
1% 27
2019
Q1
$1.07M Sell
19,794
-7,000
-26% -$393K 0.9% 30
2018
Q4
$1.57M Hold
26,794
1.42% 18
2018
Q3
$1.66M Hold
26,794
1.37% 22
2018
Q2
$1.77M Hold
26,794
1.5% 17
2018
Q1
$1.79M Buy
26,794
+4,294
+19% +$289K 1.67% 15
2017
Q4
$1.47M Buy
+22,500
New +$1.46M 1.35% 22

Other funds holding DOX

Weil Company's DOX Position: Q4 2023 in Review

Weil Company sold out of Amdocs (DOX) in Q4 2023, closing a stake of 8,970 shares — an estimated $758K sold.

Weil Company first reported a position in DOX in Q4 2017 and held it in 24 quarters. The position peaked at $2.26M in Q4 2020. 510 funds tracked by Wall St. Rank hold DOX as of Q4 2023.

  • Weil Company reported no remaining Amdocs position as of Q4 2023 after selling out during the quarter.
  • Weil Company sold 8,970 Amdocs shares in Q4 2023, an estimated $758K.
  • Weil Company first reported a position in Amdocs in Q4 2017 and held it in 24 quarters.
  • Weil Company's Amdocs position peaked at $2.26M in Q4 2020.
  • 510 funds tracked by Wall St. Rank held Amdocs as of Q4 2023.

Based on Weil Company's 13F filing for Q4 2023, filed 9 Feb 2024.